Financials CROS BORD

Equities

CBX.P

CA2274411024

Market Closed - Toronto S.E. 13:41:21 2024-06-13 EDT 5-day change 1st Jan Change
0.05 CAD -9.09% Intraday chart for CROS BORD 0.00% -65.52%

Valuation

Fiscal Period: December 2020 2021 2022 2023
Capitalization 1 0.7851 0.3473 0.3473 0.3473
Enterprise Value (EV) 1 0.7851 0.3473 0.4333 0.6533
P/E ratio -0.09 x -4.85 x -0.94 x -3.51 x
Yield - - - -
Capitalization / Revenue - - - 43,414,631 x
EV / Revenue - - - 43,414,670 x
EV / EBITDA - - -229,555 x -308,452 x
EV / FCF - 10,488,526 x -1,418,217 x 6,001,164 x
FCF Yield - 0% -0% 0%
Price to Book 1.84 x 1.89 x -11.8 x -4.74 x
Nbr of stocks (in thousands) 5,000 3,000 3,000 3,000
Reference price 2 0.1570 0.1158 0.1158 0.1158
Announcement Date 21-04-28 22-05-30 24-04-30 24-04-30
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2020 2021 2022 2023
Net sales - - - 0.008
EBITDA - - -1.513 -1.126
EBIT 1 -0.2128 -0.0617 -1.514 -1.127
Operating Margin - - - -14,087.5%
Earnings before Tax (EBT) 1 -0.2518 -0.0717 -3.866 -1.284
Net income 1 -0.2518 -0.0717 -3.866 -1.284
Net margin - - - -16,050%
EPS 2 -1.716 -0.0239 -0.1232 -0.0330
Free Cash Flow - 0.0331 -0.2449 0.0579
FCF margin - - - 723.44%
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 21-04-28 22-05-30 24-04-30 24-04-30
1CAD in Million2CAD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2020 2021 2022 2023
Net Debt - - 0.09 0.31
Net Cash position - - - -
Leverage (Debt/EBITDA) - - -0.0568 x -0.2718 x
Free Cash Flow - 0.03 -0.24 0.06
ROE (net income / shareholders' equity) - -32.6% 4,866% 172%
ROA (Net income/ Total Assets) - -15.6% -381% -411%
Assets 1 - 0.4588 1.013 0.3126
Book Value Per Share 2 0.0900 0.0600 -0.0100 -0.0200
Cash Flow per Share - - 0.0100 0
Capex - - 0 0
Capex / Sales - - - 25%
Announcement Date 21-04-28 22-05-30 24-04-30 24-04-30
1CAD in Million2CAD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA